Related Experiment Videos
Mucormycosis. Report of 11 cases
Archives of Neurology
|June 1, 1985
Summary
Mucormycosis, a severe fungal infection, often affects immunocompromised patients. Early diagnosis and treatment are crucial for improving survival rates in this potentially fatal disease.
Area of Science:
- Mycology
- Infectious Diseases
- Pathology
Background:
- Mucormycosis is a rare but aggressive fungal infection.
- It primarily affects immunocompromised individuals, including those with diabetes mellitus and acute leukemia.
- Common clinical presentations include rhinocerebral, pulmonary, disseminated, and intestinal forms.
Purpose of the Study:
- To describe the clinical characteristics and outcomes of 11 mucormycosis cases.
- To highlight the association between underlying conditions and specific clinical forms.
- To emphasize the importance of timely diagnosis and treatment for patient survival.
Main Methods:
- Retrospective case series analysis of 11 patients diagnosed with mucormycosis.
- Diagnosis confirmed via histologic examination and tissue culture from biopsies.
- Postmortem examination for two cases.
Main Results:
- Eleven cases of mucormycosis were identified between 1970 and the report date.
- Nine patients had underlying diabetes mellitus, with eight presenting rhinocerebral mucormycosis.
- Two patients with acute leukemia developed disseminated and pulmonary mucormycosis.
- Five out of eleven patients survived the infection.
Conclusions:
- Early diagnosis and prompt, appropriate medical and surgical interventions are critical for improving survival in mucormycosis.
- Recognizing the diverse clinical presentations based on underlying conditions is essential for effective management.
- Mucormycosis remains a significant challenge, necessitating aggressive therapeutic strategies.